Jeff Yordon
Founder/CEO
The startup manufactures critical injectable medications for use in acute care hospitals, outpatient clinics, and physician offices, utilizing precise formulation and aseptic processing techniques. This addresses the need for reliable access to essential treatments for patients with various medical conditions.
Raised to date
$26MRaised to date based on public sources. This may differ from the amount the company actually raised and is based only on what is publicly available on the internet.
Healthcare facilities require a consistent and reliable supply of essential injectable medications to treat patients in various acute and outpatient settings. Disruptions in the supply chain or inconsistencies in medication quality can compromise patient care and safety.
Avenacy is a specialty pharmaceutical company that focuses on providing high-quality, FDA-approved injectable medications. The company is building a resilient portfolio of products through a rigorous selection process and a diverse global network of development and manufacturing partners. Avenacy's product offerings are designed to enhance safety and streamline efficiency, with proprietary labeling to assist pharmacists in accurate medication selection and reduce the risk of administration errors. By focusing on quality, safety, and reliability, Avenacy aims to be a trusted partner for healthcare providers, ensuring access to critical medications that support better patient outcomes.
Avenacy serves acute care hospitals, outpatient clinics, and physician offices that require a reliable supply of essential injectable medications.